iBio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for iBio, Inc. (IBIO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Jun 2024Jun 2023Jun 2022Jun 2021
Operating Activities
Net Income-18.38-24.91-65.01-50.30-23.21
Depreciation & Amortization0.291.251.383.792.41
Stock Based Compensation1.532.044.394.381.59
Change in Working Capital0.48-3.175.873.24-11.15
Change in Accounts Receivable0.000.001.00-0.89-0.43
Change in Inventory0.000.00-1.02-3.870.77
Change in Accounts Payable1.83-1.49-0.631.240.05
Change in Other Working Capital-1.35-1.880.17-0.05-10.16
Other Operating Activities0.77-0.900.17-0.05-0.06
Net Cash from Operating Activities-15.30-18.55-30.44-37.48-30.06
Investing Activities
Capital Expenditures-0.02-0.21-5.74-11.63-4.92
Acquisitions0.000.00-0.69-1.760.00
Purchases of Investments0.000.0010.84-7.12-19.82
Sales/Maturities of Investments0.001.0010.8413.62-0.24
Other Investing Activities0.760.000.000.00-1.50
Net Cash from Investing Activities0.740.917.01-5.13-26.48
Financing Activities
Debt Repayment-0.77-2.03-9.63-5.83-0.33
Common Stock Issued9.7025.7311.490.0883.88
Common Stock Repurchased0.00-0.01-0.040.000.00
Dividends Paid0.000.010.040.000.00
Other Financing Activities0.00-0.09-0.02-0.37-4.71
Net Cash from Financing Activities8.9324.492.30-6.1378.84
Summary
Effect of Forex Changes on Cash0.000.000.030.000.00
Net Change in Cash-5.636.85-21.13-48.7322.29
Cash at Beginning of Period14.437.5828.6777.4055.11
Cash at End of Period8.7914.437.5828.6777.40
Free Cash Flow-15.32-18.76-36.17-49.11-34.98
Supplemental Disclosures
Interest Paid0.210.750.691.052.45